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The challenge of vaccinating in emergency
settings: policy and advocacy implications
J. Cohn
Médecins Sans Frontières, Geneva, Switzerland
Vaccination of populations living in complex humanitarian
emergencies poses a unique set of challenges. Disrupted water
and sanitation systems, destroyed health care systems, introduc-
tion and mixing of populations and crowding puts populations in
complexemergencies atparticular risk for vaccine-preventabledis-
eases such as measles, cholera and polio. Guidance from the WHO,
UNICEF and others help to provide a framework for vaccinating in
emergencies. However, signiﬁcant barriers remain. This presenta-
tion will outline these barriers, focusing on the perspectives and
experiences of Médecins Sans Frontières, and describe opportu-
nities to address key barriers and improve delivery of life saving
immunizations to populations living in emergency.
A review of the formal and grey literaturewas completed. Using
a semi-structured questionnaire, key informants were interviewed
from MSF and other important institutions. A key case study from
MSF experience in Yida camp was analyzed.
The literature review and key informant interviews identiﬁed
several key barriers to implementing vaccination campaigns in
humanitarian emergencies. Logistics, in particular requirements
for cold chain and human resource mobilization. However, vaccine
characteristics including dosage schedule, vaccine presentation
and storage volume requirements and ease of manipulating vials
were also deemed important considerations. Delays getting the
vaccines to the ﬁeld were noted at several places in the supply
chain. Finally, price of certain key vaccines such as pneumococ-
cal conjugate vaccine and the inability of humanitarian actors to
access low prices represent an important malleable barrier.
Key barriers to implementing vaccination activities in complex
humanitarian emergencies must be addressed urgently in order
to avert preventable deaths. Immediate action must be taken by
manufacturers to evaluate thermostability of core vaccines used
in emergencies in order to allow for use in the controlled tem-
perature cold chain. Manufacturers and GAVI can also bring down
prices for vaccines for use in emergency settings. Additional rec-
ommendations will be presented for important actors including
manufacturers, GAVI, distributors and vaccine implementers.
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Burden of endemic healthcare-associated
infection in Africa
D. Pittet
Director, WHO Program on Hand Hygiene and
Safety, Geneva, Switzerland
Healthcare-associated infection (HAI) occurs in every health-
care facility in every country and affects hundreds of millions of
patients annually worldwide, including in developing countries.
Although HAIs are the most frequent adverse event threatening
patient safety, reliable estimates of the global burden are hampered
by the lack of data, particularly in Africa.
For example, a recent systematic review of HAI in Africa
retrieved only a small number of articles (19) reporting studies
conducted in 10 African countries. The overall prevalence of HAI
ranged from 2.5% to 14.8%, up to twice as high as the average
European prevalence (7.1%) reported by the European Centre for
Disease Prevention and Control. However, some important aspects
need to be considered. African settingswith the capacity to conduct
surveillance studies and publish data may have greater resources
to implement infection prevention and control programmes than
those who do not collect and publish data. Thus, the real burden
of HAI is likely to be even greater in settings with weaker infras-
tructures and fewer resources. Most included studies (13/19) were
conducted in university/teaching hospitals that usually function as
referral hospitals and accept patients requiringmore complex care.
For these reasons, such hospitals generally report higher infection
rates. No national studies were identiﬁed and only one multicentre
study in two hospitals was retrieved, which makes the difﬁculties
of conducting coordinated and regular HAI surveillance in Africa all
too clear.
In 2005,WHO launched the First Global Patient Safety Challenge
“Clean Care is Safer Care” to create a global momentum and com-
mitment to reduce HAI, raise awareness of the importance of HAI
as amajor patient safety issue, build country commitment to tackle
the problem, and develop tools and guidance documents. Within
the development process, the WHO guidelines on hand hygiene in
health care and the multimodal hand hygiene improvement strat-
egy underwent a pilot test phase to assess their feasibility and
adaptability to the local context and resources available. The results
of the African test site in Bamako, Mali, clearly demonstrated that
multimodal hand hygiene promotion is feasible and effective in
low-income settings.
To reinforce the importance of patient safety, a technical paper
detailing 12 key action areas, including the reduction of HAIs, was
prepared by the WHO African Regional Ofﬁce in collaboration with
WHO Patient Safety and endorsed by all 46 African Member States.
In response to this political commitment to improve patient safety,
African Partnerships for Patient Safety was launched with the par-
ticularl aim of reducing HAI across the region.Given the lack of data
available, efforts to reduce HAI in Africa should begin with surveil-
lance activities aimed towards estimating the associated burden of
morbidity and mortality.
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